0001388658-24-000003.txt : 20240104 0001388658-24-000003.hdr.sgml : 20240104 20240104115722 ACCESSION NUMBER: 0001388658-24-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilson Daniel G. CENTRAL INDEX KEY: 0001860745 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37918 FILM NUMBER: 24510684 MAIL ADDRESS: STREET 1: 699 8TH STREET, SUITE 600 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iRhythm Technologies, Inc. CENTRAL INDEX KEY: 0001388658 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 208149544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 699 8TH STREET STREET 2: SUITE 600 CITY: San Francisco STATE: CA ZIP: 94103 BUSINESS PHONE: 415-632-5700 MAIL ADDRESS: STREET 1: 699 8TH STREET STREET 2: SUITE 600 CITY: San Francisco STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies, Inc. DATE OF NAME CHANGE: 20110429 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies Inc DATE OF NAME CHANGE: 20070201 4 1 wk-form4_1704387433.xml FORM 4 X0508 4 2024-01-02 0 0001388658 iRhythm Technologies, Inc. IRTC 0001860745 Wilson Daniel G. C/O IRHYTHM TECHNOLOGIES, INC. 699 8TH ST #600 SAN FRANCISCO CA 94103 0 1 0 0 EVP, Corp Dev Inv Rel 0 Common Stock 2024-01-02 4 S 0 7218 103.31 D 26629 D These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs. This transaction was executed in multiple trades at prices ranging from $100.55 to $103.34 per share. The price reported above reflects the weighted average sale price. The Reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Marc Rosenbaum, attorney-in-fact 2024-01-04